ROYC and Stilla Enter Strategic Partnership to Operationalise Agentic AI in Private Markets
26.5.2026 10:30:00 CEST | Business Wire | Press Release
ROYC today announced a partnership with Stilla.ai as the platform layer where ROYC will create, share and run its internally developed AI skills and agents. This operationalises the agentic AI strategy ROYC set out earlier, equipping every function across the company with the tools and resources to build and deploy their own AI agents and converting this into measurable productivity gains and accelerated product development. This will substantially accelerate launch of new platform features, improving cost efficiency at the same time as strengthening overall governance and oversight.
For ROYC’s customers and partners, the result will be shorter time-to-market for new product releases, shorter time frames moving from idea to productification and tailored customer experience from an investor services perspective.
“Our strategy is clear: AI is embedded in every aspect of our ways of working and what the ROYC Operating System does, not a side project,” said Peter Bergenwald, CTO of ROYC. “Through this partnership, our teams can now build a skill once and share it with everyone compounding across the company rather than re-explaining it in every thread. This enables employees across all our functions to have a team of agents working for them with substantial improvements in productivity as a result.”
ROYC has embedded AI into every function, across different fields such engineering, product, fund operations, investment management, investor services, legal and leadership as part of its daily operating model.
Why Stilla, and why now
“We do not want to bet on a single model and we design AI so it has context and is connected to the end-to-end workflow,” said Bergenwald. “Stilla matches that philosophy. It is model-flexible, it treats context as the thing that compounds, and it is built by a team that understood enterprise trust before they built AI on top of it.”
“The firms running private capital do not need AI that generates text. They need AI that does work, safely, with the right permissions and the right audit trail,” said Siavash Ghorbani, CEO and co-founder of Stilla. “ROYC has been thinking about this in the right way from the start, with responsibility as the foundation, ambition on top. We've built Stilla alongside world-class technology companies. ROYC is exactly the kind of partner we want as we expand into private equity.”
“What stands out about ROYC and why we are excited about this partnership is not just that they’re adopting AI, it’s how they’re thinking about it and the deep domain expertise they already have,” said Siavash Ghorbani.
“They understand that this isn’t about adding tools. It’s about rebuilding how an entire industry operates, safely, at scale, and with the right level of context and control. Private markets is one of the most complex environments you can apply AI to. ROYC has gone deep on that complexity from day one, across workflows, data, and regulatory constraints. They're exactly the kind of partner we want bringing Stilla to the private markets industry”
The partnership is built on a shared foundation: model flexibility, enterprise-grade trust, and responsibility by design. All AI capabilities operate within strict governance frameworks, with auditability and human oversight as standard.
About ROYC
ROYC's mission is to accelerate private market distribution and revenue growth across EMEA and APAC. We are the leading AI-driven private markets infrastructure platform making it easy, scalable, and revenue-generating for Wealth Managers and Asset Managers to launch, market, and operate funds across all key markets.
About Stilla
Stilla, an AI teammate and platform where organisations can create AI automations and agents to do real work. Built by the team behind Tictail, Shop, and Shop Pay, Stilla is designed for companies that treat AI as the operational layer of their business.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260526720069/en/
Contacts
For additional information or interview requests:
Mathias Leijon
Founder and President, ROYC
mathias.leijon@roycgroup.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press Release
IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press Release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO
BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare Conference26.5.2026 12:01:00 CEST | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, with a fireside chat at 10:00 a.m. EDT. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com. An archived webcast will be available on the Company’s website. About BeOne BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company has a growing global team spanning six continents who are driven by scientific excellence and exceptional speed to reach more patients than ever before. To learn more about BeOne, please visit www.beonemedicines.com
GlobalPlatform Launches Pavona: The First Open Silicon Distribution with Production-Grade Post-Quantum Cryptography26.5.2026 12:00:00 CEST | Press Release
GlobalPlatform today launched Pavona, an open-source silicon distribution that delivers production-quality, certification-ready IP components and reference top-level designs — including the first openly available post-quantum cryptography (PQC) stack for embedded silicon. The distribution includes two successfully taped-out reference designs—a standalone chip root of trust and an integrated root of trust for chiplet architectures fabricated at TSMC 3nm (N3). Pavona provides a composable framework for building secure-by-default silicon aligned with FIPS 140-3 and Common Criteria certification requirements. Twelve founding members have already committed to the initiative, spanning semiconductor manufacturers, AI companies, academic research institutions, and IP providers. The full IP repository, top-level designs, continuous integration dashboards and getting-started documentation are available today at www.pavona.org. “The world faces a rising tide of cyber insecurity, with mounting cos
Croma Skincare – Where Science Meets Skin26.5.2026 11:43:00 CEST | Press Release
With Croma Skincare, Austrian family-owned company Croma Pharma translates decades of expertise in aesthetic medicine into a modern skincare line designed for everyday results. Rather than following short-lived trends, Croma focuses on scientifically proven ingredients and pharmaceutical-grade formulations that deliver visible performance while fitting seamlessly into daily routines. Building on 50 years of experience in hyaluronic acid, Croma Pharma developed this skincare range to bridge the gap between in-clinic treatments and at-home care. The result is a streamlined portfolio that supports key skin needs such as hydration, glow, balance, and protection. The formulations combine high-performance actives including niacinamide, peptides, hyaluronic acid, and plant stem cells with lightweight, fast-absorbing textures that strengthen the skin barrier and enhance overall skin health. Hero products include: THE GLOW - a 20% stabilized vitamin C serum for radiance, antioxidant protection,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom